Navigation Links
Sunesis Reports Financial Results for the First Quarter 2009
Date:5/6/2009

me period in 2008. This decrease was primarily due to the termination of substantially all discovery research activities in June 2008.
  • General and administrative expense for the first quarter of 2009 was $2.4 million compared to $3.3 million for the same period in 2008. The decrease was primarily due to reduced administrative headcount as a result of our June 2008 restructuring.
  • Restructuring charges of $1.9 million were recorded in the three months ended March 31, 2009, including $1.3 million for lease termination activities and $0.6 million for employee severance and related benefit costs related to a restructuring in March 2009.
  • Sunesis reported a net loss of $8.4 million for the quarter ended March 31, 2009, compared to a reported net loss of $9.6 million for the same period in 2008.

  • About Voreloxin

    Voreloxin is a first-in-class anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients and in a Phase 1b/2 clinical trial combining voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML, as well as in an ongoing Phase 2 single-agent trial in platinum-resistant ovarian cancer.

    About Acute Myeloid Leukemia

    AML is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is g
    '/>"/>

    SOURCE Sunesis Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
    2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
    3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
    4. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
    5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
    6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
    7. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
    8. Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing
    9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
    10. Haemacure Reports Third Quarter 2007 Results
    11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
    (Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
    (Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
    (Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz ... has treated just about every type of injury that can result ... those same twenty-plus years, the team at Doctors on Liens ... best possible doctor. With the combined breadth of experience ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
    Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
    ... Match for Long-Term Care, GREENSBORO, N.C., ... announces that it successfully completed its,Discovery-180 technology ... Inc. ( http://www.foxlearningsystems.com ), a leading e-learning,organization ... is the innovator,of the Real Life, Real ...
    ... Enhance Collaboration and Partnership with CDC, CAMBRIDGE, ... and technical assistance firm, this month opened an ... services,to the U.S. Centers for Disease Control and ... substantial client of our firm for many years,",said ...
    ... going down the plughole: that,s how the British emerge from ... in Britain are particularly guilty of wasting shower water and ... Royal Society of Chemistry . , But men in Britain ... about what they wash down the drain. The most glaring ...
    ... join with Blue Cross and Blue Shield companies ... WASHINGTON, July 14 Recognizing that chronic,illness ... employers are,taking a "hands on" approach to improving ... smoking, obesity, and disease prevention,and management. At a ...
    ... CARLSBAD, Calif., July 14 The Chopra ... Deepak Chopra, M.D. and,David Simon, M.D. has ... -- a custom-blend oil treatment based on ... is the newest addition to The,Chopra Center,s ...
    ... first, scientists at Sydney,s Centenary Institute have mapped the ... the potential to turn the way we discover new ... for new treatments. , "These membrane proteins are the ... increased,understanding of them is vital for future drug discoveries," ...
    Cached Medicine News:Health News:Fox Learning Systems Selects Prymak's Discovery-180(TM) Technology Assessment to Guide Search for New LMS 2Health News:Fox Learning Systems Selects Prymak's Discovery-180(TM) Technology Assessment to Guide Search for New LMS 3Health News:Abt Associates Opens Atlanta Office 2Health News:British showers most wasteful and inconsiderate in Western Europe 2Health News:Employers Take Active Role in Promoting Workplace Wellness 2Health News:Employers Take Active Role in Promoting Workplace Wellness 3Health News:The Chopra Center for Wellbeing Introduces Ayurnas: A Soothing Natural Remedy for Sinus Congestion, Chronic Headaches, and Cold Symptoms 2Health News:Discovery first step to new therapies 2
    (Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
    (Date:1/23/2015)... MERIDIAN, Idaho , Jan. 23, 2015  Now available ... Patent No. 7,849,611) support that prevents ankle sprains by ... a brace, it fits securely around the outside of ... ankle mobility & comfort while still offering protection against ...
    (Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
    Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
    ... Jan. 12, 2011 InstaCare Corp. (OTC Bulletin ... non-prescription diagnostics, home testing products for the chronically ... patient diabetes programs, and a leading developer of ... announced that the company,s Board of Directors has ...
    ... Intrasphere Technologies ( http://www.intrasphere.com ), a drug safety ... to Life Sciences organizations, today announced that it ... and deliver global partner-focused training for the Oracle® ... program. Enablement 2.0 is Oracle,s commitment to the ...
    Cached Medicine Technology:InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2Intrasphere Technologies to Help Develop and Deliver Global Partner Training for the Oracle(R) Argus Safety Suite Through Oracle PartnerNetwork 2
    ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum...
    Inquire...
    Bench Top Class I Containment Cabinet Personnel Protection...
    Inquire...
    Medicine Products: